Registry for infants with Retinopathy of Prematurity in Europe

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The EU-ROP registry is a multicenter observational study across Europe aimed at collecting clinical data on infants treated for Retinopathy of Prematurity (ROP). This registry will gather information on the clinical features, treatment patterns, and long-term outcomes of ROP in various European countries without any specific interventions. The study seeks to document the natural history of the disease and variations in its presentation among different populations. By compiling this data, the registry aims to enhance understanding and management of ROP.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ROP requiring treatment according to the respective national ROP screening and treatment guidelines

Exclusion Criteria:

* Denial or absence of consent for documentation and electronic storage of personal data by parents or legal guardians

Where it's running

• University Eye Hospital Salzburg
  Salzburg, Austria Recruiting
• University Hospital Saint George
  Plovdiv, Bulgaria Recruiting
• Acibadem City Clinic Tokuda Hospital
  Sofia, Bulgaria Recruiting
• University Eye Hospital Alexandrovska
  Sofia, Bulgaria Recruiting
• University Eye Hospital Tartu
  Tartu, Estonia Recruiting
• Hospital Rothschild
  Paris, France Recruiting

+9 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Andreas Stahl, Professor — Department of Ophthalmology, University Medicine Greifswald
• Study coordinator: Andreas Stahl, Professor
• Email: andreas.stahl@med.uni-greifswald.de
• Phone: +49 3834 86

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Incidence of hypoxia during intravitreal ranibizumab injections for retinopathy of prematurity under topical anesthesia

  This study looks at how often and how severely babies with retinopathy of prematurity experience low oxygen levels during bedside eye injections with topical anesthesia.

  Recruiting Minia University · Buraidah · NCT07701759

• Effects of Skin-to-Skin Care on Premature Infants

  This study tests if regular skin-to-skin care for premature babies can help them get more of their mother's milk and reduce health problems before they go home from the hospital.

  Recruiting Baskent University Ankara Hospital · Ankara · NCT06672913

• Collecting data on the use of Aflibercept in preterm babies with eye condition

  This study is looking at how well Aflibercept works for treating eye problems in preterm babies with retinopathy of prematurity by collecting information from hospitals across the UK.

  Recruiting Bayer · Many Locations · NCT06315556

• Using intranasal dexmedetomidine to manage pain during eye exams in premature infants

  This study tests if a nasal spray of dexmedetomidine can help reduce pain for premature infants during eye exams.

  Recruiting Phase 3 Assaf-Harofeh Medical Center · Be’er Ya‘aqov, Center · NCT06067958

• Imaging the blood vessels in the eyes of premature infants

  This study is testing how blood vessels in the eyes of premature infants grow to better understand retinopathy of prematurity and help prevent childhood blindness.

  Recruiting Duke University · Durham, North Carolina and 1 other locations · NCT05558059

• Assessing retinal health in preterm infants with advanced imaging techniques

  This study is testing a new imaging technique to see if it can better spot eye problems in very preterm infants at risk for vision issues compared to regular photos.

  Recruiting Duke University · Durham, North Carolina and 1 other locations · NCT04995341

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.